Fan Xinjie, Zhu Qichu, Du Chengzhuo, Chen Jinlai, Su Yingming
Department of Respiratory and Critical Care Medicine, Datian County General Hospital, 180 Xueshan North Road, Datian County, 366100, China.
J Cardiothorac Surg. 2025 Jan 9;20(1):51. doi: 10.1186/s13019-024-03298-2.
Lung adenocarcinoma is the most common form of lung cancer and one of the most life-threatening malignant tumors. Ferroptosis is an iron-dependent regulatory cell death pathway that is crucial for tumor growth. SNX30 is a key regulatory factor in cardiac development; however, its regulatory mechanism and role in inducing ferroptosis in lung adenocarcinoma remain unclear.
This study aimed to elucidate the functions and specific mechanisms of action of SNX30 in lung adenocarcinomas.
SNX30 levels in lung adenocarcinoma cell lines (A549 and HCC827) were determined using reverse transcription quantitative real-time PCR (RT-qPCR) or western blotting. Cell proliferation and apoptosis were assessed by CCK8 and flow cytometry, respectively. The intracellular levels of total iron and Fe were detected using Iron Assay Kits. Reactive oxygen species (ROS) levels were evaluated using a DCFH-DA probe and flow cytometry. Cysteine (Cys), glutathione (GSH), and glutathione peroxidase 4 (GPX4) levels were measured using detection assay kits. Other related markers, including Ptgs2, Chac1, SETDB1 cleaved-Caspase3, and Caspase3 were analyzed by RT-qPCR or western blotting.
SNX30 is downregulated in lung adenocarcinoma cell lines. SNX30-plasmid depressed lung adenocarcinoma cell proliferation, accelerated apoptosis, enhanced cleaved-Caspase3 expression and cleaved-Caspase3/Caspase3 ratio. Ferrostatin-1 significantly reversed the effects of the SNX30-plasmid on cell ferroptosis in lung adenocarcinoma, as confirmed by the reduced ROS levels, inhibited intracellular total iron and Fe levels, decreased Ptgs2 and Chac1 expression, and increased Cys, GSH, and GPX4 release. We observed that the level of SETDB1 was lower in the SNX30-plasmid group than in the control-plasmid group, whereas the opposite results in ferrostatin-1 treated cells. SNX30 negatively regulates SETDB1 expression in lung adenocarcinoma cells. The upregulation of SETDB1 reversed the effects of the SNX30-plasmid on ferroptosis in lung adenocarcinoma cells.
SNX30 inhibits lung adenocarcinoma cell proliferation and induces ferroptosis by regulating SETDB1 expression.
肺腺癌是肺癌最常见的形式,也是最具生命威胁的恶性肿瘤之一。铁死亡是一种铁依赖性调节性细胞死亡途径,对肿瘤生长至关重要。分选连接蛋白30(SNX30)是心脏发育中的关键调节因子;然而,其在肺腺癌中诱导铁死亡的调节机制和作用仍不清楚。
本研究旨在阐明SNX30在肺腺癌中的功能及具体作用机制。
采用逆转录定量实时聚合酶链反应(RT-qPCR)或蛋白质免疫印迹法检测肺腺癌细胞系(A549和HCC827)中SNX30的水平。分别通过细胞计数试剂盒(CCK8)和流式细胞术评估细胞增殖和凋亡情况。使用铁检测试剂盒检测细胞内总铁和铁离子(Fe)水平。使用2′,7′-二氯二氢荧光素二乙酸酯(DCFH-DA)探针和流式细胞术评估活性氧(ROS)水平。使用检测试剂盒测量半胱氨酸(Cys)、谷胱甘肽(GSH)和谷胱甘肽过氧化物酶4(GPX4)水平。通过RT-qPCR或蛋白质免疫印迹法分析其他相关标志物,包括前列腺素内过氧化物合酶2(Ptgs2)、阳离子扩散促进蛋白1(Chac1)、组蛋白赖氨酸N-甲基转移酶1(SETDB1)、裂解的半胱天冬酶3(cleaved-Caspase3)和半胱天冬酶3(Caspase3)。
肺腺癌细胞系中SNX30表达下调。SNX30质粒抑制肺腺癌细胞增殖,加速细胞凋亡,增强裂解的Caspase3表达及裂解的Caspase3/Caspase3比值。铁死亡抑制剂1(Ferrostatin-1)显著逆转了SNX30质粒对肺腺癌细胞铁死亡的影响,表现为ROS水平降低、细胞内总铁和Fe水平受抑制、Ptgs2和Chac1表达下降以及Cys、GSH和GPX4释放增加。我们观察到SNX30质粒组中SETDB1水平低于对照质粒组,而在Ferrostatin-1处理的细胞中结果相反。SNX30在肺腺癌细胞中负向调节SETDB1表达。SETDB1的上调逆转了SNX30质粒对肺腺癌细胞铁死亡的影响。
SNX30通过调节SETDB1表达抑制肺腺癌细胞增殖并诱导铁死亡。